mRNA |
azacitidine |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.02 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.12 |
0.02 |
mRNA |
NVP-231 |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.02 |
mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
0.1 |
0.02 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.02 |
mRNA |
CIL55A |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.03 |
mRNA |
AGK-2 |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.03 |
mRNA |
TAE684 |
CCLE |
pan-cancer |
AAC |
-0.1 |
0.03 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.03 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.03 |